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LETTERS TO EDITOR 
GLUCOSE-CONTAINING ORGAN PRESERVATION SOLUTIONS AND INTRACELLULAR ACIDOSIS 
We read with interest the excellent review by Belzer and 
Southard (1) on the principles of organ preservation by cold 
storage following vascular flushing. The UW solution developed 
by the authors holds the promise that improved preservation 
will be achieved, especially for organs other than the kidney, 
both in duration of safe storage and in quality of function in 
the early postreimpiantation phase. One concept that we would 
like to question. however. is the view that glucose present in 
the preservation solution (as in EuroCollins') can contribute to 
the developing acidosis during hypothermia. particularly in the 
liver. We have been undertaking l1p NMR spectroscopy studies 
on the response of liver to vascular flush and cold storage. using 
the conventional hypertonic citrate solution (which contains 
no glucose) and Collins' solution (a phosphate-based solution 
with high glucose content) (2,3). Using the chemical shift of 
the inorganic phosphate signal. we have followed the pH 
changes in the livers with time at hypothermia. In these exper-
imental studies on the rat it is apparent that the pH fall in 
both solutions is identical (reaching by 8 hr pH 6.85±0.04 in 
citrate-flushed organs. and 6.86±O.03 in Collins' -flushed or· 
gans). Factors other than lactate accumulation can influence 
intracellular pH. including the hydrolysis of ATP, which lib-
erates protons (5)-and from our studies we have no reason to 
implicate glucose contained in the storage solution as a major 
contributing factor in the hepatic acidosis. Indeed, in other 
studies (to be reported) when we used a phosphate-based pres-
ervation solution in which the glucose was completely replaced 
by mannitol, the intrahepatic pH fall was again identical to 
that seen in the glucose-containing medium. The metabolic 
pathways in play during hypothermia of mammalian cells still 
remain largely to be identified, and the interesting combina-
tions of solutes in the solution developed by Belzer and Sou-
thard open up exciting new possibilities for organ preservation. 
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PRESERVATION OF LIVERS WITH UW OR EURO-COLLINS' SOLUTION 
Beginning in October 1987, we have used the preservation 
solution developed for livers by Jamieson (1), Kalayoglu (2), 
and Belzer and their associates at the University of Wisconsin 
(UW). The first 185 livers were preserved for an average of 
1O.1±S (SD) hr (range 4 to 24 hr). The results were compared 
with those obtained with Euro-Collins' solution in the preced-
ing 180 livers. which were preserved for 5.9±1.4 hr (range 3.5-
9.5). The most meaningful data were from 151 primary trans-
plantations in the UW group and from a comparable 144 
primary transplantations in the Euro-Collins' group. 
In spite of the longer preservation. the UW livers performed 
at least as well as those preserved with Euro-Collins. The UW 
organs survived at 3 months at a higher rate (76% versus 68%); 
permitted a better 3-month patient survival (83% versus 81 %); 
and had a lower rate of primary nonfunction. a reduced need 
for retransplantation (17 versus 29), and a lowered incidence 
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of the hepatic artery thrombosis (8 versus 19) which has been 
most common in infants and small children. With the UW 
solution. there was no correlation between the time of preser-
vation up to 24 hr and liver function abnormalities during the 
first postoperative week (Fig. 1). 
The remarkable effectiveness of the UW solution has 
changed many aspects of liver transplantation. The longer safe 
preservation time has permitted more effective use of organs 
that can be stored while awaiting for operating room facilities 
or personnel to become available. It has allowed procurement 
of grafts from cities once considered to be too distant. It has 
taken the stress from the recipient operation and allowed more 
deliberate hepatectomy techniques. Since formal analysis of 
our first 185 cases. these conclusions have been strengthened 
by experience with another 250 liver preservations with a 
maximum cold ischemia time of 35 hr with succeas. 
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FIGURE 1. Highest serum aspartate aminotraDlferaae (AST) in the 
first week from livers preserved with UW solution (A) versus Euro-
Collins' solution (8). 
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HEPATITIS IN LIVING-DONOR RENAL ALLOGRAFT RECIPIENTS 
The effect of liver disease on the survival of renal allograft 
recipients is still controversial (1-5). We have therefore reo 
viewed our experience with hepatitis in such patients. 
All 44 7 patients who had living-donor kidney transplantation 
at our center from 1976 to 1985 were studied. Donor selection, 
immunosuppression regimen, and transfusion protocol have 
been reported earlier (6-8). Liver function tests and screening 
for hepatitis B surface antigen (HBsAg) were done at monthly 
intervals, or more frequently if necessary, up to 6 months after 
transplantation. and at frequent intervals thereafter. Serum 
was examined for HbsAg by the reverse passive hemagglutina-
tion test. Liver biopsies were performed when indicated. 
Hepatitis was defined as a two-fold elevation of serum aspar-
tate aminotransferase or serum alanine aminotransferase, or 
both. with or without an increase in serum bilirubin. Chronicity 
was defined as persistence of hepatitis for more than 6 months. 
A total of 66 (14.8%) of the patients had hepatitis. All bad 
received azathioprine. and 11 also received potentially hepato-
toxic drugs such as rifampicin, isoniazid. pyrazinamide, and 
alpha methyldopa. The mean follow-up was 17 months (range 
6-74 months), during that period 35 of the 66 patients (53%) 
had chronic hepatitis and the reat transient hepatitis. 
Of the 35 with chronic hepatitis, 16 had persistent HBs 
antigenemia. 6 transient antigenemis, and the reat were always 
negative on HBsAg testing. Four patients with chronic hepatitis 
who had severe disease had liver biopsies that showed chronic 
active hepatitis in 2, micronodular cirrhosis in 1, and hemosid-
erosis in 1. Five patients with chronic hepatitis and persistent 
antigenemis died of hepatocellular failure, and another died of 
gram-negative bacterial septicemia. One patient with chronic 
hepatitis and transient antigenemia died of hepatocellular fail-
ure, 2 of gram-negative bacterial septicemia. 2 of severe bacte-
rial respiratory infection, and 2 of disseminated tubereuloais. 
Of the 31 with transient hepatitis, 6 had persistent HBs 
antigenemia. 16 transient antigenemia. and the rest were al· 
ways negative on HBsAg testing. Liver biopsy of two patients 
